Internal Medicine, Infectious Disease · Warner Robins, GA
NPI
1659311645
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1118 Morningside Dr, Ste B
Warner Robins, GA, 31088
Phone (478) 396-8783
Groups this clinician bills Medicare through
Medicare paid, 2024
$172K
2,573 services
Medicare patients, 2024
341
Average age 74
Drug cost, 2024
$59K
109 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nalini A Patel was code 99232 (hospital e&m - subsequent), 2,112 times for 274 patients. In total Nalini A Patel billed 2,573 services in 9 codes, and Medicare paid $172K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,112 | 274 | $58.99 | $125K |
| 99233 Hospital E&M - Subsequent | Facility | 160 | 95 | $89.26 | $14K |
| 99222 Hospital E&M - Initial | Facility | 139 | 130 | $96.74 | $13K |
| 99223 Hospital E&M - Initial | Facility | 139 | 131 | $129.95 | $18K |
By year: 2022 $261K for 4,060 services; 2023 $246K for 3,490 services; 2024 $172K for 2,573 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nalini A Patel prescribed most often to Medicare patients was Daptomycin, with 33 prescriptions and refills. In total Nalini A Patel wrote 109 Medicare prescriptions that cost $59K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 33 | 33 | Under 11 | $40K |
| Ceftriaxone Ceftriaxone Sodium | 17 | 17 | Under 11 | $1,025 |
| Oxacillin Sodium Generic | 14 | 14 | Under 11 | $10K |
| Doxycycline Hyclate Generic | 11 | 11 | Under 11 | $111 |
Brand drugs: - claims; generic drugs: 106 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Nalini A Patel were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.